"We have known since the founding of our herd that we have captured the high islet yield characteristic in our animals. Use of the state-of-the-art Infinium HD PorcineSNP60 BeadChip technology to link specific genetic profiles with this characteristic will allow us to further refine our
selection and breeding program to provide an unlimited source of pig islet cells to accelerate the availability and affordability of islet transplantation to cure diabetes," says Tom Spizzo, Spring Point Project's Director of Operations. "We are sincerely grateful for GeneSeek's donation of genotyping services to make this significant advance possible."
Currently, several litters of second generation piglets are being raised at the DRWF Islet Resource Facility operated by Spring Point Project. These pigs are the first pigs in the facility which can serve as donors of islet cells suitable for transplantation in diabetes patients. The first clinical trials are slated to begin within one year.
Established in 1998 with headquarters in Lincoln, NE and facilities in the UK and India, GeneSeek, Inc. is a privately held, global biotechnology company dedicated to providing quality DNA-based diagnostic and discovery products and services. GeneSeek is committed to being an innovative and dynamic company serving the agribusiness, food safety, biomedical and pharmaceutical markets. GeneSeek's high throughput genotyping capabilities range from one SNP to a million SNPs per sample and are relevant to gene discovery, diagnostic testing, marker-assisted breeding and identity management across many species. www.GeneSeek.com
About Spring Point Project
Spring Point Project is a nonprofit organization with the mission to provide a
|SOURCE Spring Point Project|
Copyright©2009 PR Newswire.
All rights reserved